These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Radiotherapy of oral malignant melanomas in dogs. Blackwood L; Dobson JM J Am Vet Med Assoc; 1996 Jul; 209(1):98-102. PubMed ID: 8926220 [TBL] [Abstract][Full Text] [Related]
9. Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma. Horiuchi Y; Tominaga M; Ichikawa M; Yamashita M; Okano K; Jikumaru Y; Nariai Y; Nakajima Y; Kuwabara M; Yukawa M Microbiol Immunol; 2010 Mar; 54(3):152-9. PubMed ID: 20236425 [TBL] [Abstract][Full Text] [Related]
10. Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up. Saellstrom S; Sadeghi A; Eriksson E; Segall T; Dimopoulou M; Korsgren O; Loskog AS; Tötterman TH; Hemminki A; Ronnberg H Front Vet Sci; 2021; 8():695222. PubMed ID: 34368282 [TBL] [Abstract][Full Text] [Related]
11. Cancer immunology and canine malignant melanoma: A comparative review. Atherton MJ; Morris JS; McDermott MR; Lichty BD Vet Immunol Immunopathol; 2016 Jan; 169():15-26. PubMed ID: 26827834 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients. Schiza A; Wenthe J; Mangsbo S; Eriksson E; Nilsson A; Tötterman TH; Loskog A; Ullenhag G J Transl Med; 2017 Apr; 15(1):79. PubMed ID: 28427434 [TBL] [Abstract][Full Text] [Related]
14. Canine limbal melanoma: 30 cases (1992-2004). Part 1. Signalment, clinical and histological features and pedigree analysis. Donaldson D; Sansom J; Scase T; Adams V; Mellersh C Vet Ophthalmol; 2006; 9(2):115-9. PubMed ID: 16497236 [TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival. Brockley LK; Cooper MA; Bennett PF N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437 [TBL] [Abstract][Full Text] [Related]
20. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study]. Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]